Clinical Trials Logo

Clinical Trial Summary

To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.


Clinical Trial Description

The overall objective of the study will be to examine the safety and efficacy of the VASCADE closure device compared to manual compression (standard of care) to achieve hemostasis after endovascular procedures requiring access within a severely diseased CFA. This study will be a retrospective single center review of 200 patients undergoing endovascular procedures utilizing vascular access within a severely diseased CFA between 2018 and 2020 at Yale New Haven Hospital. A random selection of patients undergoing hemostasis with manual compression (n = 100) and VASCADE vascular closure system (n = 100) will be conducted. The two groups will then be statistically compared with respect to 48-hour and 30-day safety and efficacy outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04745624
Study type Observational
Source Yale University
Contact
Status Completed
Phase
Start date August 20, 2020
Completion date December 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04299906 - SOLARIS Peripheral PMCF Trial N/A
Recruiting NCT05821829 - Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy
Not yet recruiting NCT04545281 - Physician-Initiated PMCF Trial Investigating the Solaris Vascular Stent Graft for the Treatment of Iliac Lesions Phase 4